Trial
NCT03889756
Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Yale University
Collaborators
—
Condition
Major Depressive Disorder
Intervention
Ketamine infusion
Why stopped
No more funding available to continue since we could not recruit throughout the pandemic.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-04-24